You are here: Industry Insights > Cancer Trial

News List

Deciphera expands cancer trial after seeing early data fiercebiotech
January 04, 2019
Deciphera Pharmaceuticals has posted data from a phase 1 trial of its small molecule switch control inhibitor of CSF1R, DCC-3014. The early-phase data have emboldened Deciphera to expand the trial to include patients with....
AstraZeneca’s tremelimumab fails another phase 3 cancer trial fiercebiotech
December 28, 2018
AstraZeneca’s tremelimumab has come up short in another phase 3 trial. Having failed to improve outcomes in metastatic non-small cell lung cancer (NSCLC).....
Novartis’ PI3K drug hits goal in phase 3 breast cancer trial, laying groundwork for talks with regulators fiercebiotech
August 24, 2018
Novartis’ PI3K inhibitor BYL719 has met the primary endpoint in a phase 3 breast cancer trial. The hit on the progression-free survival endpoint sets Novartis up to start talking to regulators about getting the drug to market.
Can-Fite says liver cancer trial is delayed—but it could be good news fiercebiotech
June 25, 2018
Israeli microcap Can-Fite BioPharma won’t get a readout from its midstage trial of liver cancer candidate namodenoson as soon as it hoped, but said the data so far are looking good.
RedX Pharma Cancer Trial Paused: Serious Side Effects biospace
March 30, 2018
Redx Pharma, based in Alderley Park, UK, dosed its first patient for the Porcupine inhibitor RXC004 on February 6.